- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT02591329
Increasing Household Purchase and Child Consumption of Calcium Products
Increasing Household Purchase and Child Consumption of Calcium Products: A Randomised Controlled Trial
The objective of this research is to test the effectiveness of persuasive messages targeted at parents who have children who consume inadequate amounts of calcium. Specifically, the effectiveness of the intervention material on increase a) the purchase of calcium-rich products by parents, and b) the consumption of calcium-rich products in the parent and child will be examined in 400 families across Canada. Families will receive either the targeted intervention materials or standard of care generic nutrition materials retrieved from Health Canada's website. Materials will be delivered to parents during weeks 0, 8, 16, and 22 of the study. Monitoring of parents' calcium product purchases and consumption behaviour in both parents and children will occur at week 0,12, 24 weeks (immediately post-intervention) and at 52 weeks (i.e., 6-month follow-up). Purchases will be verified by grocery receipts made during the aforementioned weeks. Parents will self-report on their dietary consumption as well as their child's using a food frequency questionnaire. The study hypotheses are as follows:
- Parents in the experimental condition will purchase more calcium-rich products as compared to parents in the control condition.
- Parents and children in the experimental condition will consume more calcium rich products as compared to parents and children in the control condition.
- Perceived outcome expectancies of consuming calcium-rich products will increase to a greater extent in parents in the experimental condition as compared to parents in the control condition.
- Self-regulatory efficacy to consume calcium-rich products will increase to a greater extent in parents in the experimental condition as compared to parents in the control condition.
- Perceived social support and role modelling behaviour will be highest in parents in the experimental condition as compared to parents in the control condition.
- Self-regulatory efficacy and outcome expectancies will mediate the changes in calcium-rich product purchases and consumption.
Visão geral do estudo
Status
Condições
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
British Columbia
-
Kelowna, British Columbia, Canadá, V1V 1V7
- Health and Exercise Psychology Laboratory
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Parent of a child between the ages of 4 and 10
- The child consumes less than the recommended daily intake of calcium (1300mg for youth aged 9-10 and 1000mg for children aged 4-8)
- Parent and child have no dietary restrictions, allergies, or medical reasons for limiting intake of dairy products
- Parent can read and speak English
Exclusion Criteria:
- Dietary restrictions, allergies, or medical reasons for limiting intake of dairy products
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
---|---|
Experimental: Experimental
The experimental condition (EXP) will receive the targeted intervention material developed and designed by the researchers using focus group discussions with parents.
This information will include salient benefits of the consumption of calcium-rich products.
In addition, self-regulatory strategies will be provided to encourage purchasing and consumption of calcium-rich products and address any potential barriers to purchase and consumption.
Material will sent on four different occasions via mail.
At time one (week 0) participants will be sent a 13-month calendar, at time 2 (week 8) participants will be sent a grocery pad and a recipe book.
At time 3 and 4 (week 16 and 22 respectively) participants will be sent a newsletter.
|
|
Comparador Ativo: Standard Care
Individuals in the Control condition (CON) will receive general healthy eating materials including Canada's Food Guide, Healthier Grocery Shopping Guide and Cooking with Kids.
Material will sent on four different occasions via mail.
At time one (week 0) participants will be sent a 13-month calendar, at time 2 (week 8) participants will be sent a note pad and an activity book.
At time 3 and 4 (week 16 and 22 respectively) participants will be sent a newsletter.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Changes in Purchasing Behaviour
Prazo: Baseline (before the intervention begins), week-12 (mid point of the intervention), week-24 (immediately after the intervention), week-52 (6-months after the intervention is complete)
|
The purchase of calcium-rich products will be assessed objectively via grocery receipts over a 7-day period.Receipts will be mailed to UBC Okanagan.
Information provided within receipts will be entered into the ESHA nutrition analyses software.
Specifically, changes in mg of calcium purchased will be examined over the above time points.
|
Baseline (before the intervention begins), week-12 (mid point of the intervention), week-24 (immediately after the intervention), week-52 (6-months after the intervention is complete)
|
Changes in Adult Consumption Behaviour
Prazo: Baseline (before the intervention begins), week-12 (mid point of the intervention), week-24 (immediately after the intervention), week-52 (6-months after the intervention is complete)
|
Consumption of calcium by the parent be assessed using a 3-day food diary at baseline, week-12, week-24 and week-52.
Data provided with the food diary will be entered into the ESHA nutrition analyses software and changes in mg of calcium consumed over time will be examined.
|
Baseline (before the intervention begins), week-12 (mid point of the intervention), week-24 (immediately after the intervention), week-52 (6-months after the intervention is complete)
|
Changes in Child Consumption Behaviour
Prazo: Baseline (before the intervention begins), week-12 (mid point of the intervention), week-24 (immediately after the intervention), week-52 (6-months after the intervention is complete)
|
Consumption of calcium by the child be assessed using a 3-day food diary to be completed by the parent at baseline, week-12, week-24 and week-52.
Data provided with the food diary will be entered into the ESHA nutrition analyses software and changes in mg of calcium consumed over time will be examined.
|
Baseline (before the intervention begins), week-12 (mid point of the intervention), week-24 (immediately after the intervention), week-52 (6-months after the intervention is complete)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Changes in Outcome Expectations
Prazo: Baseline (before the intervention begins), week-12 (mid point of the intervention), week-24 (immediately after the intervention), week-52 (6-months after the intervention is complete)
|
A total of 21 outcomes will be assessed in relation to expected outcomes of consuming adequate calcium for the parent and 8 outcomes in relation to expected outcomes of the parents child consuming adequate calcium.
Outcomes are scored on a scale from 0 (very unlikely) to 9 (very likely).
|
Baseline (before the intervention begins), week-12 (mid point of the intervention), week-24 (immediately after the intervention), week-52 (6-months after the intervention is complete)
|
Changes in Self-Regulatory Efficacy Beliefs
Prazo: Baseline (before the intervention begins), week-12 (mid point of the intervention), week-24 (immediately after the intervention), week-52 (6-months after the intervention is complete)
|
Distinct components of self-regulatory efficacy include confidence in one's ability to schedule, goal set, and overcome barriers to purchasing and consuming calcium-rich products.
A total of 11 items will be assessed and the items will be scored on a scale from 0% (Not at all confident) to 100% (Extremely confident).
|
Baseline (before the intervention begins), week-12 (mid point of the intervention), week-24 (immediately after the intervention), week-52 (6-months after the intervention is complete)
|
Changes in Parent Social Support
Prazo: Baseline (before the intervention begins), week-12 (mid point of the intervention), week-24 (immediately after the intervention), week-52 (6-months after the intervention is complete)
|
The degree to which parents perceive themselves as offering support to their child in regards to consumption of calcium-rich products will be assessed using an adapted version of the Social Support for Diet Survey (Sallis et al., 1987).
Questions will be adapted to pertain to the child's specific consumption of calcium-rich products.
|
Baseline (before the intervention begins), week-12 (mid point of the intervention), week-24 (immediately after the intervention), week-52 (6-months after the intervention is complete)
|
Changes in Perceived Role Modelling
Prazo: Baseline (before the intervention begins), week-12 (mid point of the intervention), week-24 (immediately after the intervention), week-52 (6-months after the intervention is complete)
|
The degree to which parents perceive themselves as role modelling consumption of calcium-rich products will be assessed using an adapted version of Cullen and colleagues (2001) family and peer influences on fruit, juice and vegetable consumption.
This measure was adapted in a similar way to the current study by Draxten and colleagues (2014).
|
Baseline (before the intervention begins), week-12 (mid point of the intervention), week-24 (immediately after the intervention), week-52 (6-months after the intervention is complete)
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
- H14-02762
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Cuidado padrão
-
Compedica IncProfessional Education and Research InstituteRecrutamentoÚlcera do pé diabéticoEstados Unidos, Canadá
-
Integra LifeSciences CorporationIntegriumRescindidoÚlceras do Pé DiabéticoEstados Unidos, Porto Rico, Canadá, África do Sul
-
ULURU Inc.Navy Advanced Medical Development (NAMD) CommandAtivo, não recrutandoFerimentos e LesõesEstados Unidos
-
Vanderbilt University Medical CenterConcluídoDoença do Refluxo Gastroesofágico (DRGE) | Doença de Refluxo Não Erosiva (NERD)Estados Unidos
-
Vanderbilt University Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)ConcluídoDispepsia Funcional | Doença do Refluxo Gastroesofágico (DRGE) | Esofagite Eosinofílica (EoE)Estados Unidos
-
Cishan Hospital, Ministry of Health and WelfareConcluídoFragilidade | Sarcopenia | Unidade de Cuidados de Longo PrazoTaiwan
-
Saint-Joseph UniversityConcluídoEstabilidade do Implante | Perda óssea peri-implantar | Espessura Vertical dos Tecidos MolesLíbano
-
Icahn School of Medicine at Mount SinaiInternational Biophysics Corporation; SPARK HealthcareRescindidoCovid19 | Doença de obstrução pulmonar crônica | Tosse crônicaEstados Unidos
-
Memorial Sloan Kettering Cancer CenterAmerican Cancer Society, Inc.; Go2 Foundation for Lung CancerRecrutamento
-
ULURU Inc.United States Department of DefenseRecrutamentoÚlcera por Pressão Estágio II | Úlcera por Pressão Estágio III | Úlcera por Pressão, Estágio IVEstados Unidos